Kindred Biosciences reported $-7330000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Adma Biologics ADMA:US $ -14.26M 0.39M
Bayer BAYN:GR € 3035M 1119M
BioSpecifics Technologies BSTC:US 6.54 6.76
Dynavax Technologies DVAX:US $ 10.78M 19.34M
Eli Lilly And LLY:US $ 1797.7M 218.8M
Idexx Laboratories IDXX:US $ 288.04M 12.86M
JAZZ PHA JAZZ:US $ 77.72M 157.36M
Kindred Biosciences KIN:US $ -7.33M 0.63M
Minerva Neurosciences NERV:US $ -8.96M 1.46M
Novavax NVAX:US $ -343.42M 137.1M
Phibro Animal Health PAHC:US $ 27M 1.05M
Zoetis ZTS:US $ 838M 30M